|
[Related PubMed/MEDLINE]
Total Number of Papers: 107
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain. |
ASA |
| 2 |
2020 |
CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation. |
iDC, mCD40L, TA |
| 3 |
2020 |
Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex. |
--- |
| 4 |
2020 |
Expression of CD40 Ligand on T Cells and Soluble CD40 Ligand in Children With Kawasaki Disease: A Single-Center Preliminary Study From North India. |
CD40L, CI, IVIG, KD |
| 5 |
2020 |
Yin Yang-1 suppresses CD40 ligand-CD40 signaling-mediated anti-inflammatory cytokine interleukin-10 expression in pulmonary adventitial fibroblasts by promoting histone H3 tri-methylation at lysine 27 modification on interleukin-10 promoter. |
CD40L, EZH2, IL-10, mRNA, PAH, YY-1 |
| 6 |
2019 |
RNA-binding protein SFPQ cooperates with HDAC1 to suppress CD40 transcription in pulmonary adventitial fibroblasts. |
CD40L, DBHS, H3K27ac, HDAC1, PAH |
| 7 |
2018 |
A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation. |
Ang II, CD40L, WT |
| 8 |
2018 |
Dengue Virus Induces the Release of sCD40L and Changes in Levels of Membranal CD42b and CD40L Molecules in Human Platelets. |
DENV-2 |
| 9 |
2018 |
Induction of Apoptosis in Cancer Cells of pre-B ALL Patients after Exposure to Platelets, Platelet-Derived Microparticles and Soluble CD40 Ligand. |
7-AAD, PBMCs, PLT, Plt-MPs, pre-B ALL |
| 10 |
2018 |
Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis. |
MBP, MCP-1, MDC, MRI, PDGF-AA, RRMS, TGF-alpha, TNF-alpha |
| 11 |
2017 |
Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. |
aPL, APS |
| 12 |
2017 |
Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS. |
CD40L, FSGS, GECs, NS |
| 13 |
2016 |
Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism. |
BP, EH, PA |
| 14 |
2016 |
Immunometabolic biomarkers of inflammation in Behcet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens. |
BD, IL, MCP-1, MPO, OPG, SAA |
| 15 |
2016 |
Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction. |
BBB, HAND, MuLV-1, WT |
| 16 |
2016 |
NORE1A induction by membrane-bound CD40L (mCD40L) contributes to CD40L-induced cell death and G1 growth arrest in p21-mediated mechanism. |
mCD40L |
| 17 |
2016 |
Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2alpha in HIV-1 patients on abacavir-based therapies. |
ABC, NOX2 |
| 18 |
2015 |
CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy. |
CD40L, GO, MAPKs, NF-kappaB, OFs, PCR, PI3K, VCAM-1 |
| 19 |
2015 |
Endothelial Dysfunction and Altered Coagulation As Mediators of Thromboembolism in Behcet Disease. |
BD |
| 20 |
2015 |
Is signal peptide-CUB-EGF domain-containing protein1 a diagnostic biomarker in patients with hypertensive crises. |
HI, HT, HU, SCUBE1 |
| 21 |
2015 |
Mechanisms of Nifedipine-Downregulated CD40L/sCD40L Signaling in Collagen Stimulated Human Platelets. |
CCB, MMP-2, NO, ROS |
| 22 |
2015 |
Self-complementary adeno-associated virus 5-mediated gene transduction of a novel CD40L mutant confers direct antitumor effects in lung carcinoma. |
CD40L, scAAV5, scAAV5-CD40L-M |
| 23 |
2015 |
Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease. |
GCF |
| 24 |
2014 |
Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma. |
CD40L, PDAC, ROC |
| 25 |
2014 |
PPARgamma ligands decrease hydrostatic pressure-induced platelet aggregation and proinflammatory activity. |
PPARgamma, TZDs |
| 26 |
2014 |
Total adiponectin is inversely associated with platelet activation and CHA₂DS₂-VASc score in anticoagulated patients with atrial fibrillation. |
AF, APN |
| 27 |
2013 |
An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid. |
ELISAs, G-CSF, IL, IP, MDC, MIP, OA, PCA, PDGF, RANTES, SF |
| 28 |
2013 |
CD40 ligand as a potential biomarker for atherosclerotic instability. |
ACI, CAS, PBMCs |
| 29 |
2013 |
CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications. |
T2DM |
| 30 |
2013 |
Quantification of cardiovascular disease biomarkers via functionalized magnetic beads and on-demand detachable quantum dots. |
CVD |
| 31 |
2013 |
Soluble CD40 ligand stimulates CD40-dependent activation of the beta2 integrin Mac-1 and protein kinase C zeda (PKCzeta) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst. |
PKCzeta |
| 32 |
2013 |
The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome. |
CD40L, HELLP |
| 33 |
2013 |
The role of soluble CD40L in immunosuppression. |
--- |
| 34 |
2012 |
Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages. |
ABCA1, apoA-I, CD40L, ELISA, FC, HDL, NF-kB, TRAF-6 |
| 35 |
2012 |
Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages. |
DCs |
| 36 |
2012 |
Chronic hyper-reactivity of platelets resulting in enhanced monocyte recruitment in patients after ischaemic stroke. |
sCD62P, TRAP |
| 37 |
2012 |
Does anti-TNF therapy cause any change in platelet activation in ankylosing spondylitis patients? A comparative study. |
AS, PMC, sE-selectin |
| 38 |
2012 |
Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders. |
BBB, Gr1, HAND, Tat |
| 39 |
2012 |
Involvement of nuclear factor kappaB in platelet CD40 signaling. |
CD40L, MAPK, NF-kappaB |
| 40 |
2012 |
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. |
2alpha, sCD36 |
| 41 |
2012 |
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. |
bFGF, CFU-F, ICAM-1, MSC, PDGF-AA, PL, TGF-beta1, VCAM-1 |
| 42 |
2012 |
Prevention of non-immune mediated transfusion-related acute lung injury; from blood bank to patient. |
lysoPCs, TRALI |
| 43 |
2012 |
Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma. |
CD40L, HGF, IL-6, Ki-67 PI, MM, VEGF |
| 44 |
2012 |
The CD40-CD40L axis and IFN-gamma play critical roles in Langhans giant cell formation. |
CD40L, Con A, DC-STAMP, LGCs |
| 45 |
2011 |
Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates. |
--- |
| 46 |
2011 |
Inhibitory effects of lipoteichoic acid from Staphylococcus aureus on platelet function and platelet-monocyte aggregation. |
LTA |
| 47 |
2011 |
Platelet activation in chronic cocaine users: effect of short term abstinence. |
MPA, NAP-2, RANTES |
| 48 |
2010 |
CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha(IIb)beta(3). |
IIb, MMP-2 |
| 49 |
2010 |
Modified serum profiles of inflammatory and vasoconstrictive factors in patients with emotional stress-induced acute coronary syndrome during World Cup Soccer 2006. |
ACS, ET, hs-CRP, MCP, RANTES, sVCAM, TNF |
| 50 |
2010 |
Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients. |
ADP, TRAP |
| 51 |
2010 |
Soluble CD40L (CD154) is increased in patients with shock. |
SIRS |
| 52 |
2009 |
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. |
Hcy, hs-CRP |
| 53 |
2009 |
Elevated platelet-monocyte complexes in patients with psoriatic arthritis. |
CRP, PMC, PNC, PsA, sE-selectin |
| 54 |
2009 |
Increased concentrations of soluble vascular cell adhesion molecule-1 and soluble CD40L in subjects with metabolic syndrome. |
MS, sE-selectin, sVCAM-1 |
| 55 |
2009 |
Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. |
CRP, ELISA, IL-1beta, IL-1ra, IL-6, MIA, TNF-alpha |
| 56 |
2008 |
CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. |
EC, siRNA, VEGF |
| 57 |
2008 |
Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study. |
CD40L, CVD |
| 58 |
2008 |
Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro. |
CMVIg, IVIG |
| 59 |
2008 |
Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. |
AD, HUCBCs, IgM |
| 60 |
2008 |
Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. |
APs, BC, CD40L, PCs, PLTs, PRP, sCD62 |
| 61 |
2008 |
Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure. |
BNP, CD40L, CHF, ELISA, NYHA |
| 62 |
2008 |
Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction. |
AF, vWF |
| 63 |
2008 |
Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity. |
CHF, MPC, MPM, MPV, pCD40L |
| 64 |
2008 |
The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin. |
AN, CD40L, MS |
| 65 |
2008 |
The regulation of autoreactive B cells during innate immune responses. |
DCs, SLE |
| 66 |
2008 |
Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure. |
HF, TNF-alpha |
| 67 |
2007 |
CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling. |
CD40L |
| 68 |
2007 |
CD40-CD40 ligand signal induces the intercellular adhesion molecule-1 expression through nuclear factor-kappa B p50 in cultured salivary gland epithelial cells from patients with Sjogren's syndrome. |
ICAM-1, NF-kappaB, PDTC, SG cells, SS |
| 69 |
2007 |
Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. |
CD40L, DSS, HGF, HIFs, HIMECs, IBD, IL-8, LPT, VEGF |
| 70 |
2007 |
Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. |
MAP |
| 71 |
2007 |
Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. |
HIV-1 |
| 72 |
2007 |
Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. |
CD40L, Ig |
| 73 |
2007 |
Increased serum levels of circulating CD40 ligand in patients with bullous pemphigoid: preliminary results. |
BP, CD40L, PV |
| 74 |
2007 |
Phase I study of eptifibatide in patients with sickle cell anaemia. |
ACS, CD40L, SCA |
| 75 |
2007 |
Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention. |
CD40L, CRP, MFI, PCI |
| 76 |
2006 |
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. |
CAD, CD40L, FVIIa, IL-1beta, IL-6, MDD, sP-selectin, SSRI, TNF-alpha |
| 77 |
2006 |
Differential regulation of soluble and membrane CD40L proteins in T cells. |
--- |
| 78 |
2006 |
Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction. |
AMI, CD40L, CS, CS-A, IL, max, MMP, PCI |
| 79 |
2006 |
Soluble CD40 ligand in prediction of acute severe pancreatitis. |
--- |
| 80 |
2006 |
Soluble CD40 ligand levels in otherwise healthy subjects with impaired fasting glucose. |
hs-CRP, IFG |
| 81 |
2006 |
Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study. |
CURES, IGT, MS, NGT, sP-selectin |
| 82 |
2006 |
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. |
CD, CD40L, HIMEC, PBT |
| 83 |
2005 |
Analysis of serum soluble CD40 ligand in patients with influenza virus-associated encephalopathy. |
CD40L, EBV, IE, IFS |
| 84 |
2005 |
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. |
CD40L, MMP-9 |
| 85 |
2005 |
Chorioamnionitis is associated with increased CD40L expression on cord blood platelets. |
CA, IL-6 |
| 86 |
2005 |
Inverse correlation between soluble CD40 ligand and soluble CD40 is absent in patients with unstable angina. |
CD40L, MMP, sCD40, UA |
| 87 |
2005 |
Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. |
--- |
| 88 |
2005 |
Soluble CD40 ligand levels in patients with hypertension. |
CD40, hs-CRP |
| 89 |
2005 |
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. |
ALCS, CRF, CRP, CV |
| 90 |
2004 |
Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. |
CD40L, TNF-alpha |
| 91 |
2004 |
CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island. |
CD40L, EC, MeCP2, VEGF |
| 92 |
2004 |
Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L. |
AA, ELISA, ITP |
| 93 |
2004 |
Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. |
mp-CD40L, PPP, serum-I |
| 94 |
2004 |
Elevated circulating CD40L concentrations in patients with systemic sclerosis. |
dSSc, lSSc, SLE, SSc |
| 95 |
2004 |
Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome. |
ACS, AMI, SA, UA |
| 96 |
2004 |
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. |
GP, MMPs |
| 97 |
2003 |
CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling. |
ERK, JNK, mAb, MEK, MM, NF, PI3K, uPA |
| 98 |
2003 |
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. |
CD40L |
| 99 |
2003 |
Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. |
CD40L, FC, IVIG, KD |
| 100 |
2003 |
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. |
MCP, PTCA |
|
A Search Service for Abbreviation / Long Form
